Cita APA (7a ed.)
Schieszer, J. (2018). Investigational Tx shows promise for NMIBC: 48% complete response rate for BCG-refractory disease observed. Urology Times, 46(8), 18.
Cita Chicago Style (17a ed.)
Schieszer, John. "Investigational Tx Shows Promise for NMIBC: 48% Complete Response Rate for BCG-refractory Disease Observed." Urology Times 46, no. 8 (2018): 18.
Cita MLA (9a ed.)
Schieszer, John. "Investigational Tx Shows Promise for NMIBC: 48% Complete Response Rate for BCG-refractory Disease Observed." Urology Times, vol. 46, no. 8, 2018, p. 18.
Precaución: Estas citas no son 100% exactas.